Bank Of America Corp Anavex Life Sciences Corp. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Bank Of America Corp holds 275,265 shares of AVXL stock, worth $2.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275,265

Previous 600,359 54.15%

Holding current value

$2.38 Million

Previous $2.53 Million 38.29%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.11 - $7.04 $1.34 Million - $2.29 Million	-325,094 Reduced 54.15%	275,265 $1.56 Million
Q2 2024 Aug 14, 2024	SELL	$3.39 - $5.02 $850,106 - $1.26 Million	-250,769 Reduced 29.46%	600,359 $2.53 Million
Q1 2024 May 15, 2024	BUY	$4.55 - $6.75 $2.94 Million - $4.36 Million	646,190 Added 315.31%	851,128 $4.33 Million
Q4 2023 Feb 14, 2024	SELL	$5.04 - $9.95 $270,280 - $533,588	-53,627 Reduced 20.74%	204,938 $1.91 Million
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $4.43 Million - $5.49 Million	-578,210 Reduced 69.1%	258,565 $2.1 Million
Q1 2023 May 12, 2023	BUY	$8.32 - $11.75 $2.75 Million - $3.88 Million	330,321 Added 65.22%	836,775 $7.17 Million
Q4 2022 Feb 10, 2023	BUY	$7.65 - $14.43 $1.95 Million - $3.68 Million	254,742 Added 101.2%	506,454 $4.69 Million
Q3 2022 Nov 14, 2022	BUY	$8.9 - $12.86 $1.24 Million - $1.78 Million	138,780 Added 122.89%	251,712 $2.6 Million
Q2 2022 Aug 12, 2022	SELL	$7.31 - $12.84 $1.17 Million - $2.06 Million	-160,291 Reduced 58.67%	112,932 $1.13 Million
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $1.22 Million - $2.21 Million	124,953 Added 84.27%	273,223 $3.36 Million
Q4 2021 Feb 08, 2022	BUY	$16.88 - $23.31 $1.97 Million - $2.72 Million	116,703 Added 369.7%	148,270 $2.57 Million
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $2 Million - $3.06 Million	-118,875 Reduced 79.02%	31,567 $567,000
Q2 2021 Sep 13, 2021	BUY	$10.16 - $28.86 $1.53 Million - $4.34 Million	150,442 New	150,442 $3.44 Million

Others Institutions Holding AVXL

# of Institutions

155

Shares Held

27.3M

Call Options Held

515K

Put Options Held

838K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Anavex Life Sciences Corp. Transaction History